.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Apollo Hospitals Enterprise has announced a significant corporate restructure to streamline its medical equipment business. Specifically, the group will appoint Shobana Kamineni as the executive chairperson of its upcoming public arm, Apollo Healthtech. Consequently, this leadership move aims to drive the unit's growth and unlock deep business value.
This transition aligns with a broader plan to separate the digital health and pharmacy segments from core operations. Therefore, Apollo Hospitals hopes to establish clear, focused growth platforms that appeal directly to public market investors. In addition, the demerger process will likely reach completion by late FY27, subject to necessary approvals. Ultimately, the company targets an impressive annualized revenue of around Rs 25,000 crore at the time of its market debut.
Furthermore, Apollo Healthtech plans to implement robust governance standards to reassure prospective public investors. Specifically, independent directors will comprise at least half of the newly formed board. Meanwhile, promoter and investor nomination rights will remain linked to a proposed ten percent shareholding threshold. As a result, this strong governance framework will ensure high accountability and transparency as the business scales up.
The equipment arm specializes in key clinical supplies, including pressure-relief mattresses, specialized seating solutions, and care chairs. Currently, these products serve major institutional healthcare settings, including the National Health Service in the United Kingdom. Consequently, this established market presence positions the healthcare firm for rapid global expansion under its new leadership team.
Q1: Who will serve as the executive chairperson of Apollo Healthtech?
Specifically, Apollo proposed Shobana Kamineni to lead the newly restructured medical equipment arm as its executive chairperson.
Q2: When does the company expect to complete the listing of Apollo Healthtech?
Consequently, Apollo Hospitals expects to complete the listing of Apollo Healthtech by late FY27, subject to approvals.
Q3: What products does Apollo Healthtech supply?
In addition, the company supplies medical equipment like pressure-relief mattresses, care chairs, and specialized seating solutions.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Apollo Hospitals Enterprise plans to appoint promoter director Shobana Kamineni as the executive chairperson of its soon-to-be listed medical equipment arm, Apollo Healthtech. This key transition aligns with a major corporate restructuring aimed at enhancing governance standards and boosting market value.
last month
A parliamentary panel has urged the FSSAI to finalise front-of-pack nutrition labelling regulations without further delay. The committee stressed that simple, color-coded indicators for sugar and clear warning labels are vital to combat dietary non-communicable diseases and guide informed consumer choices.
3 days back
A comprehensive analysis of the NFHS-5 data regarding postpartum anemia in India, exploring the prevalence, severity, and the socioeconomic and regional factors contributing to this public health challenge for clinicians seeking to improve maternal health outcomes.
Last week
A study in Greece reveals that 46-80% of heatwave deaths are linked to climate change. This analysis explores the implications for public health and clinical practice, particularly for elderly and vulnerable populations facing rising global temperatures in regions like India.
2 weeks back
Nearly 80% of Indians suffer from inadequate Vitamin D, causing silent bone weakening and sudden fractures. This expert guide reviews why mega-dose therapy is critical for high-risk patients, the key factors driving widespread deficiency, and the mandatory medical evaluations needed to protect skeletal health.
last month
A parliamentary standing committee has directed FSSAI to expedite front-of-pack nutrition labelling regulations. The panel highlighted that over two years of delay since the 2022 draft notification leaves consumers relying on complex numerical labels, urging simple color-coded sugar indicators and warnings.
3 days back
